Biomet Vanguard Minimally Invasive Knee System To Launch By November
This article was originally published in The Gray Sheet
Executive Summary
Biomet believes its Vanguard series instrumented, minimally invasive unicondylar knee system will help grow the company's 40% U.S. market share in unicompartmental knees
You may also be interested in...
Merck Sale Of Orthopedic Assets Will Grant European Autonomy To Biomet
Biomet will redouble European sales and marketing efforts after assuming 100% ownership of its joint venture with Merck KGaA, the firm says
Merck Sale Of Orthopedic Assets Will Grant European Autonomy To Biomet
Biomet will redouble European sales and marketing efforts after assuming 100% ownership of its joint venture with Merck KGaA, the firm says
Biomet Total TMJ Study Bias, Adverse Event Rates Acceptable – Panel
The concentration of Total TMJ temporomandibular joint replacement procedures at two centers in Biomet's pivotal trial contributed to favorable statistical analysis of the device